OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea
· Delayed Price · Currency is KRW 9,500.00
+110.00 (1.17%)
At close: Apr 29, 2026
OPTUS Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 165,701 | 121,409 | 98,534 | 85,935 | 101,603 | 112,144 | Upgrade
|
| Market Cap Growth | 70.40% | 23.21% | 14.66% | -15.42% | -9.40% | -19.02% | Upgrade
|
| Enterprise Value | 126,878 | 91,465 | 40,627 | 22,719 | 41,394 | 35,907 | Upgrade
|
| Last Close Price | 9390.00 | 6880.00 | 6100.00 | 5320.00 | 6168.81 | 6533.49 | Upgrade
|
| PE Ratio | 12.86 | 10.69 | 9.56 | 7.99 | 20.27 | 11.34 | Upgrade
|
| PS Ratio | 1.90 | 1.39 | 1.20 | 1.19 | 1.73 | 1.96 | Upgrade
|
| PB Ratio | 1.00 | 0.74 | 0.69 | 0.64 | 0.82 | 0.88 | Upgrade
|
| P/TBV Ratio | 1.11 | 0.81 | 0.77 | 0.64 | 0.82 | 0.88 | Upgrade
|
| P/FCF Ratio | - | - | - | 9.43 | - | - | Upgrade
|
| P/OCF Ratio | 10.21 | 7.48 | 11.07 | 6.91 | 49.68 | 15.86 | Upgrade
|
| EV/Sales Ratio | 1.46 | 1.05 | 0.50 | 0.31 | 0.71 | 0.63 | Upgrade
|
| EV/EBITDA Ratio | 9.34 | 6.73 | 3.25 | 1.83 | 4.75 | 2.79 | Upgrade
|
| EV/EBIT Ratio | 14.30 | 10.31 | 4.78 | 2.78 | 7.89 | 3.43 | Upgrade
|
| EV/FCF Ratio | -4.48 | - | - | 2.49 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.07 | 0.12 | 0.17 | 0.30 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.23 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.35 | -0.49 | -0.47 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.86 | -2.86 | -4.00 | -5.35 | -6.77 | -5.76 | Upgrade
|
| Net Debt / FCF Ratio | 1.37 | 1.37 | 17.21 | -7.29 | 14.91 | 20.89 | Upgrade
|
| Asset Turnover | 0.49 | 0.49 | 0.52 | 0.51 | 0.43 | 0.43 | Upgrade
|
| Inventory Turnover | 3.00 | 3.00 | 2.92 | 2.52 | 2.53 | 3.00 | Upgrade
|
| Quick Ratio | 2.09 | 2.09 | 3.09 | 6.00 | 7.12 | 7.13 | Upgrade
|
| Current Ratio | 2.62 | 2.62 | 3.69 | 7.02 | 8.34 | 8.00 | Upgrade
|
| Return on Equity (ROE) | 7.36% | 7.36% | 7.41% | 8.31% | 3.99% | 8.04% | Upgrade
|
| Return on Assets (ROA) | 3.10% | 3.10% | 3.37% | 3.58% | 2.38% | 4.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.20% | 8.07% | 8.97% | 10.17% | 6.52% | 22.05% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.40% | 5.40% | 5.90% | 6.00% | 4.20% | 8.10% | Upgrade
|
| Earnings Yield | 6.85% | 9.35% | 10.46% | 12.52% | 4.93% | 8.82% | Upgrade
|
| FCF Yield | -17.07% | -23.30% | -2.95% | 10.60% | -3.89% | -3.17% | Upgrade
|
| Payout Ratio | - | - | 14.80% | 14.09% | 32.01% | 16.22% | Upgrade
|
| Buyback Yield / Dilution | -1.88% | -1.88% | -0.53% | 4.22% | 1.07% | 0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.